Health Minister Urges Foreign Pharmaceuticals To Invest In Vietnam (Vietnam)
This article was originally published in PharmAsia News
Executive Summary
A year into Vietnam's membership in the World Trade Organization is a time for foreign pharmaceutical companies to invest in the country, its health minister says. Dang Minh Quang offered frank discussions with foreign companies and government agencies about Vietnam's laws and regulations. The country already has taken steps to simplify and improve its licensing procedures for drug-making firms and is nearing completion of its national pharmaceutical law and other legal issues. The ministry also plans to consider separate licenses for foreign pharmaceutical companies for producing new medicines and drugs for fatal diseases in Vietnam. (Click here for more ) "Health Ministry Calls For FDI In Pharmaceutical Sector" VietnamNet Bridge (12/7/07)
You may also be interested in...
Lilly Can Rest Easy As Tirzepatide Scores Phase III Sleep Apnea Win
Topline results from two studies in obstructive sleep apnea among obese adults showed efficacy crossing the 50% threshold that physicians have called clinically meaningful.
China’s Public Payer Wants To Define Innovative Drugs As Those With ‘Novel Benefits’
China’s public payer perceives innovative drugs in a different way from that of the country’s top drug regulator, a former senior healthcare security official with knowledge of the matter reveals. The posture has unnerved pharma companies, which have been hit by sharp price discounts.
Change Is Constant For Pneumococcal Vaccines: US CDC Prepares For Merck’s V116
As Merck’s 21-valent vaccine approaches its 17 June user fee goal, the US CDC’s vaccine committee is looking at new adult age-based recommendations and bracing for a full pipeline led by GSK’s 24-valent candidate.